Title: Prevalence of Stress Hyperglycemia in Acute Stroke Patients in Central India
Authors: Dr Jeetandra Kumar Sharma, Dr Dharmendra Kumar Mekle, Dr Bhavishya Rathore
DOI: http://dx.doi.org/10.18535/jmscr/v4i7.62
Abstract
Aim of study was to study prevelance of stress hyperglycemia in acute stroke patients.
Methods: This was a observational cross-sectional study, consisting of consecutive 117 patients admitted in emergency medical ward.
Results: Total 117 patients are enrolled in our study. 47 (40.17%) patients were found stress hyperglycemic and it is significant (p-value is 0.0249, result is significant if p value < 0.05). Age group of the stress hyperglycemic patients ranged from 17years to 82 years with maximum (53.19%) patients in the age group of 41years to 60 years. Mean age of patient was 40.27 ± 1.44 years (95% CI 38.83 – 41.71 year, SD – 15.06, SE – 1.44 ). There were 35 (74.47%) stress hyperglycemic male and 12 (25.53%) stress hyperglycemic female patients.
Conclusions: Expected proportion of stress hyperglycemia was observed among stroke patients.
References
1. Langouche, l., & van den berghe g. 2006, glucose metabolism and insulin therapy. Critical care clinics, 22 ,119-126.
2. Farnoosh Farrokhi, Dawn Smiley, Guillermo E. Umpierrez- Glycemic control in non-diabetic critically ill patients.Best Practice & Reesearch Clinical Endocrinology & Metabolism 25 (2011), 813-824.
3. Greci ls, kailasam m, malkani s et al. Utility of hba(1c) levels for diabetes case finding in hospitalized patients with Hyperglycemia. Diabetes care 2003; 26(4): 1064–1068.
4. Sonksen ph. Home monitoring of blood glucose by diabetic patients. Acta endocrinologica. Supplementum. (copenh) 1980;238: 145–155,74.
5. Saladin, k., s., 2007 anatomy & physiolosy: the unity of form and function. Newyork , ny: mcgraw- hill.
6. Mechanick, j., i., 2006 metabolic mechani-sms of stress hyperglycemia. Journal of parenteral and enteral nutrition, 30, 157-163.
7. Falciglia m., 2007 couses and consequences of hyperglycemia in critical illness. Current opinion in clinical nutrition and metabolic care, 10,498-503.
8. Van den bergh g et al. Intensive insulin therapy in critically ill patients. Nejm 2001; 345: 1359- 1367
9. Krinsley js. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo clin proc. 2003;78(12):1471-1478.
10. Bochicchio, g.v., salzano,l., joshi, m., bochicchio, k., & scaiea, t. M.,2005 admission preoperative glucose is predictive of morbidity and mortality in trauma patient who require immediate operative intervention. The american surgeon, 71, 171-174.
11. American Diabetes Association. Standard of medical care for patients with diabetes mellitus. Clinical practice recommendatio-ns 2001. Diabetes Care 2001; 24 (Suppl 1)
12. S. L. Norris, N. Lee, S. Thakurta and B. K. S. Chan. Exenatide efficacy and safety : a systematic review. Diabet. Med. 2009; 26, 837–846
13. Donahoe SM, Stewart GC et al. Diabetes and mortality following Acute Coronary Syndromes . JAMA 2007; 298(7): 765-775.
14. NICE-SUGAR study investigators, Finfer S, Chittock DR ,Su Sy ,Blair D, Foster D, Dhingra V, Bellomo R , Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK , Mac Ather C, Mc Donald E, Mitchell I, Myberg JA, Norton R , Poter J, Robinson BG, Ranco, Intensive versus conventional glucose control in critically ill patients. N Engl J Med .2009; 360 (13):1283-97.
15. Egi M, Bellomo R, Stachowski E, French CJ, Hart G, Variability of blood glucose concentration and short term mortality of critically ill patients, Anesthesiology. 2006, 105(2),244-52.